Correlation of hematological parameters, antibodies and cytokines with disease activity in systemic lupus erythematosus: a cross-sectional study

被引:0
作者
Zivkovic, Valentina [1 ,2 ]
Cvetkovic, Tatjana [1 ,3 ]
Dinic, Biljana Radovanovic [1 ,4 ]
Jurisic, Vladimir [5 ]
机构
[1] Univ Nis, Fac Med, Nish, Serbia
[2] Inst Treatment & Rehabil, Nish, Niska Banja, Serbia
[3] Univ Clin Ctr, Clin Nephrol, Nish, Serbia
[4] Univ Clin Ctr, Clin Gastroenterol & Hepatol, Nish, Serbia
[5] Univ Kragujevac, Fac Med Sci, Svetozara Markov 69, Kragujevac 34000, Serbia
关键词
Biomarkers; Disease activity; Neutrophils; Platelets; Sistemic lupus erythematosus; TO-LYMPHOCYTE RATIO; ANTI-C1Q ANTIBODIES; DAMAGE INDEX; NEUTROPHIL; PLATELET; MARKERS; NLR; BIOMARKERS; NUCLEOSOME; CANCERS;
D O I
10.1186/s43166-023-00222-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The aim of the study was to investigate the association of neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte ratios (PLR) with standard inflammation parameters, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), complement component C3, anti-double-stranded deoxyribonucleic acid (anti-dsDNA), anti-nucleosome and anti-C1q antibodies, and serum and urinary monocyte-chemoattractant protein-1 (MCP-1) with disease activity in patients with systemic lupus erythematosus (SLE).Results This study included 160 patients (145 female and 15 male patients), hospitalized at the Rheumatology Department. A positive correlation between NLR and ESR (p < 0.01), anti-dsDNA antibodies (p < 0.05), and PLR (p < 0.001) was obtained, with a negative correlation with C3 (p < 0.005). PLR shows a positive correlation with ESR (p < 0.001), CRP (p < 0.005), anti-dsDNA antibodies (p < 0.001), anti-nucleosome antibodies (p < 0.05), and urine MCP-1 (p < 0.05), with a negative correlation with C3 (p < 0.005). Univariate analysis showed that all the examined laboratory parameters were independent predictors of disease activity (p < 0.001), while the method of standard multiple regression analysis revealed the most significant ESR and serum MCP-1 (p < 0.05).Conclusions NLR and PLR, as inexpensive and accessible biomarkers, can help in routine clinical practice for the estimation of disease activity in SLE patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Serum cytokines to predict systemic lupus erythematosus clinical and serological activity
    Moreno-Torres, Victor
    Castejon, Raquel
    Martinez-Urbistondo, Maria
    Gutierrez-Rojas, Angela
    Vazquez-Comendador, Jose
    Tutor, Pablo
    Duran-Del Campo, Pedro
    Mellor-Pita, Susana
    Rosado, Silvia
    Vargas-Nunez, Juan-Antonio
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (07): : 1676 - 1686
  • [22] Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: A cross-sectional study
    Campos-Lopez, Bertha
    Meza-Meza, Monica R.
    Parra-Rojas, Isela
    Ruiz-Ballesteros, Adolfo, I
    Vizmanos-Lamotte, Barbara
    Francisco Munoz-Valle, Jose
    Montoya-Buelna, Margarita
    Cerpa-Cruz, Sergio
    Bernal-Hernandez, Luis E.
    De La Cruz-Mosso, Ulises
    CLINICAL IMMUNOLOGY, 2021, 222
  • [23] Beneficial effects associated to a healthy lifestyle in systemic lupus erythematosus: A cross-sectional study
    Vordenbaeumen, Stefan
    Kleefisch, Martin
    Sokolowski, Alexander
    Duesing, Christina
    Richter, Jutta G.
    Brinks, Ralph
    Schneider, Matthias
    Chehab, Gamal
    LUPUS, 2023, 32 (07) : 855 - 863
  • [24] Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study
    Ceccarelli, F.
    Orefice, V.
    Perrone, G.
    Pirone, C.
    Perricone, C.
    Truglia, S.
    Miranda, F.
    Pacucci, V. A.
    Spinelli, F. R.
    Galoppi, P.
    Alessandri, C.
    Valesini, G.
    Conti, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : 450 - 454
  • [25] Systemic lupus erythematosus disease activity and neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: a cross-sectional case-control study
    Abdalhadi, Safaa
    Khalayli, Naram
    Al-Ghotani, Basel
    Kudsi, Maysoun
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (05): : 1448 - 1453
  • [26] SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus
    Yang, Chi-Hui
    Wang, Xin-Yi
    Zhang, Yi-Hui
    Ding, Ning
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [27] Methyl donor micronutrients, CD40-ligand methylation and disease activity in systemic lupus erythematosus: A cross-sectional association study
    Vordenbaeumen, Stefan
    Sokolowski, Alexander
    Rosenbaum, Anna
    Gebhard, Claudia
    Raithel, Johanna
    Duesing, Christina
    Chehab, Gamal
    Richter, Jutta G.
    Brinks, Ralph
    Rehli, Michael
    Schneider, Matthias
    LUPUS, 2021, 30 (11) : 1773 - 1780
  • [28] APPLICATION OF THE ICF CHECKLIST IN THE CHINESE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: A CROSS-SECTIONAL STUDY
    Li, Wei
    Feng, Chenchen
    He, Xiaoli
    Wu, Yan
    Wu, Juan
    Hu, Xiaokun
    Zhao, Shuzhen
    ACTA MEDICA MEDITERRANEA, 2018, 34 (05): : 1281 - 1288
  • [29] Serum beta-2 microglobulin as a predictor of nephritis, disease activity, and damage score in systemic lupus erythematosus: a cross-sectional study
    Dalia Mohamed Gamal
    Fatma Mohammed Badr
    Sara Ibrahim Abd el Fattah Taha
    Nouran M. Moustafa
    Mohammed Abd El Monem Teama
    Rheumatology International, 2023, 43 : 323 - 333
  • [30] Serum beta-2 microglobulin as a predictor of nephritis, disease activity, and damage score in systemic lupus erythematosus: a cross-sectional study
    Gamal, Dalia Mohamed
    Badr, Fatma Mohammed
    Taha, Sara Ibrahim Abd El Fattah
    Moustafa, Nouran M.
    Teama, Mohammed Abd El Monem
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (02) : 323 - 333